Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Takeda Pharmaceutical ADR Rep 0.5 Ord Shs V.TAK


Primary Symbol: TAK

Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.


NYSE:TAK - Post by User

Post by rory17on Nov 25, 2012 4:49pm
155 Views
Post# 20641564

Yukoninvestor

Yukoninvestor

NIcely put. I could not have said it better than that. These guy's track record speaks for itself and it is going to be difficult for this group to finance based upon what they have done to date. I expect we will see trench results at some point here on Rosebute via Shawn Ryan who apparently is becoming more involved. May be there is a trade here at these levels , but it is risky and does nothing to solve the fact that Zack and the boys are running out of money by continuing top pay themselves these outlandish fees and salaries. If they are successful with a financing, it is huge dilution at these prices. Kaminak and Atac have continually put out great resource numbers and their share prices are at lows over the last year. If there is a short term trade , you had better be nimble if you get the chance. A real pity to see this group treat this company as their own piggy bank at the expense of the shareholders.

Bullboard Posts